tetano
Editor, Senior Moderator
Australas J Dermatol. 2020 Mar 26. doi: 10.1111/ajd.13295. [Epub ahead of print]
Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.
Rademaker M[SUP]1[/SUP], Baker C[SUP]2,[/SUP][SUP]3[/SUP], Foley P[SUP]4[/SUP], Sullivan J[SUP]5[/SUP], Wang C[SUP]3[/SUP].
Author information
Abstract
Coronavirus disease 2019 (COVID-19) is the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as named by the International Committee on Taxonomy of Viruses (ICTV). There is very limited evidence base to formulate specific advice for dermatology patients on immunomodulators with regards to COVID-19. The following is based on expert opinion, taking into account known risks of influenza (a negative sense single-stranded RNA virus) and other, positive-sense single-stranded, RNA virus infections (such as SARS, MERS, and the common cold). An Australia/New Zealand consensus document is in development.
This article is protected by copyright. All rights reserved.
PMID:32219857DOI:10.1111/ajd.13295
Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.
Rademaker M[SUP]1[/SUP], Baker C[SUP]2,[/SUP][SUP]3[/SUP], Foley P[SUP]4[/SUP], Sullivan J[SUP]5[/SUP], Wang C[SUP]3[/SUP].
Author information
Abstract
Coronavirus disease 2019 (COVID-19) is the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as named by the International Committee on Taxonomy of Viruses (ICTV). There is very limited evidence base to formulate specific advice for dermatology patients on immunomodulators with regards to COVID-19. The following is based on expert opinion, taking into account known risks of influenza (a negative sense single-stranded RNA virus) and other, positive-sense single-stranded, RNA virus infections (such as SARS, MERS, and the common cold). An Australia/New Zealand consensus document is in development.
This article is protected by copyright. All rights reserved.
PMID:32219857DOI:10.1111/ajd.13295